Race Oncology
RAC.AX
#8749
Rank
โ‚น10.22 B
Marketcap
โ‚น58.88
Share price
-1.30%
Change (1 day)
-33.94%
Change (1 year)

P/E ratio for Race Oncology (RAC.AX)

P/E ratio at the end of 2023: -19.0

According to Race Oncology's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -16.9767. At the end of 2023 the company had a P/E ratio of -19.0.

P/E ratio history for Race Oncology from 2016 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2023-19.0-18.24%
2022-23.2-63.1%
2021-62.9322%
2020-14.91275.63%
2019-1.08-42.55%
2018-1.89-18.57%
2017-2.32-70.75%
2016-7.92

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.